Effects of KPC Variant and Porin Genotype on the in Vitro Activity of Meropenem-Vaborbactam Against Carbapenem-Resistant Enterobacteriaceae.
Meropenem-Vaborbactam: A Carbapenem and Beta-Lactamase Inhibitor With Activity Against Carbapenem-Resistant Enterobacteriaceae
Vaborbactam
Meropenem-Vaborbactam Tested Against Contemporary Gram-Negative Isolates Collected Worldwide During 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.
Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam Against Carbapenem-Resistant Enterobacteriaceae in an in Vitro Hollow-Fiber Model.
Activity of Meropenem-Vaborbactam Against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.
Cloxacillin/meropenem/vaborbactam
Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam.
SIMPLE PREPARATION METHOD FOR VABORBACTAM
Pharmacokinetics of the Meropenem Component of Meropenem-Vaborbactam in the Treatment of KPC-Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient